2nd May 2007, London, UK - EyeforPharma, world renowned leader in providing business strategy information and conferences for the pharmaceutical industry, has revealed that the World Health Organisation (WHO) will be announcing major findings of its Global Learn to Live with Asthma Programme at the forthcoming Patient Compliance & Communication Conference to be held in Geneva 4-5th June.
In addition the WHO will present the latest information from its Global Alliance against Chronic Respiratory Diseases (GARD) study to improve patient compliance.
The event, which is in its 4th year, brings together the top 10 pharma companies to answer the challenges of strengthening communication and measuring the ROI of patient compliance programmes to improve patient retention.
Major speakers include Scott Ratzan of J&J, Len Starnes of Bayer Schering Pharma and Nikolai Khaltaev from WHO, while case studies will be presented by companies such as Pfizer, J&J, Merck, Roche, Bayer Schering Pharma and NICE.
Aimed at Marketing Directors, Brand Directors, Patient Relations Managers, Marketing Communications Managers, Senior Product Managers and many more from pharma companies across Europe, the conference brings together thought-leaders to share insights on improving physician/patient communication.
For more information visit www.eyeforpharma.com/pceu2007/
EyeforPharma is a global pharmaceutical business strategy information provider with a highly reputable and worldwide presence in the Pharma industry. It is renowned for producing top level conferences that attract the highest level of speakers to deliver presentations on cutting edge pharmaceutical business strategies. EyeforPharma provides business intelligence and analysis online at www.eyeforpharma.com and through an email briefing twice a month. EyeforPharma also has a very strong foothold in the European, US and Japanese markets.
T: +44 (0) 2073757173
F: +44 (0) 2073757576
Issuers of news releases, not Targetwire, are solely responsible for the accuracy of the content.